UniProt ID | CAPZB_HUMAN | |
---|---|---|
UniProt AC | P47756 | |
Protein Name | F-actin-capping protein subunit beta | |
Gene Name | CAPZB | |
Organism | Homo sapiens (Human). | |
Sequence Length | 277 | |
Subcellular Localization | Cytoplasm, cytoskeleton. Cytoplasm, myofibril, sarcomere. | |
Protein Description | F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. Plays a role in the regulation of cell morphology and cytoskeletal organization.. | |
Protein Sequence | MSDQQLDCALDLMRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLLCDYNRDGDSYRSPWSNKYDPPLEDGAMPSARLRKLEVEANNAFDQYRDLYFEGGVSSVYLWDLDHGFAGVILIKKAGDGSKKIKGCWDSIHVVEVQEKSSGRTAHYKLTSTVMLWLQTNKSGSGTMNLGGSLTRQMEKDETVSDCSPHIANIGRLVEDMENKIRSTLNEIYFGKTKDIVNGLRSIDAIPDNQKFKQLQRELSQVLTQRQIYIQPDN | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSDQQLDCA ------CCHHHHHHH | 44.09 | 25159151 | |
2 | Acetylation | ------MSDQQLDCA ------CCHHHHHHH | 44.09 | 18491316 | |
14 | Methylation | DCALDLMRRLPPQQI HHHHHHHHHCCHHHH | 44.26 | - | |
23 | Ubiquitination | LPPQQIEKNLSDLID CCHHHHHHHHHHHHH | 65.89 | - | |
34 | Phosphorylation | DLIDLVPSLCEDLLS HHHHHHHHHHHHHHH | 37.87 | 26434776 | |
41 | Phosphorylation | SLCEDLLSSVDQPLK HHHHHHHHCCCCCHH | 35.30 | 26434776 | |
42 | Phosphorylation | LCEDLLSSVDQPLKI HHHHHHHCCCCCHHH | 29.68 | 26434776 | |
53 | Ubiquitination | PLKIARDKVVGKDYL CHHHHHHCCCCCCEE | 33.01 | - | |
57 | 2-Hydroxyisobutyrylation | ARDKVVGKDYLLCDY HHHCCCCCCEEECCC | 31.43 | - | |
57 | Ubiquitination | ARDKVVGKDYLLCDY HHHCCCCCCEEECCC | 31.43 | - | |
57 | Acetylation | ARDKVVGKDYLLCDY HHHCCCCCCEEECCC | 31.43 | 26822725 | |
59 | Phosphorylation | DKVVGKDYLLCDYNR HCCCCCCEEECCCCC | 12.69 | 28152594 | |
64 | Phosphorylation | KDYLLCDYNRDGDSY CCEEECCCCCCCCCC | 15.88 | 28152594 | |
73 | Phosphorylation | RDGDSYRSPWSNKYD CCCCCCCCCCCCCCC | 23.61 | 25159151 | |
76 | Phosphorylation | DSYRSPWSNKYDPPL CCCCCCCCCCCCCCC | 27.16 | 23532336 | |
78 | Ubiquitination | YRSPWSNKYDPPLED CCCCCCCCCCCCCCC | 45.58 | 21890473 | |
78 | Acetylation | YRSPWSNKYDPPLED CCCCCCCCCCCCCCC | 45.58 | 23749302 | |
78 | Ubiquitination | YRSPWSNKYDPPLED CCCCCCCCCCCCCCC | 45.58 | 21890473 | |
78 (in isoform 1) | Ubiquitination | - | 45.58 | 21890473 | |
78 (in isoform 2) | Ubiquitination | - | 45.58 | 21890473 | |
88 | Sulfoxidation | PPLEDGAMPSARLRK CCCCCCCCCCHHHHH | 3.09 | 21406390 | |
90 | Phosphorylation | LEDGAMPSARLRKLE CCCCCCCCHHHHHHH | 16.97 | 23532336 | |
95 | Acetylation | MPSARLRKLEVEANN CCCHHHHHHHHHHCC | 54.30 | 26051181 | |
95 | Ubiquitination | MPSARLRKLEVEANN CCCHHHHHHHHHHCC | 54.30 | - | |
95 | Ubiquitination | MPSARLRKLEVEANN CCCHHHHHHHHHHCC | 54.30 | 21890473 | |
95 (in isoform 2) | Ubiquitination | - | 54.30 | 21890473 | |
95 (in isoform 1) | Ubiquitination | - | 54.30 | 21890473 | |
95 | Malonylation | MPSARLRKLEVEANN CCCHHHHHHHHHHCC | 54.30 | 26320211 | |
107 | Phosphorylation | ANNAFDQYRDLYFEG HCCHHHHHHHHHEEC | 14.13 | - | |
135 | Acetylation | FAGVILIKKAGDGSK EEEEEEEEECCCCCC | 32.88 | 30587443 | |
136 | Acetylation | AGVILIKKAGDGSKK EEEEEEEECCCCCCC | 51.08 | 26051181 | |
142 | Acetylation | KKAGDGSKKIKGCWD EECCCCCCCCCCCCC | 65.14 | 26051181 | |
145 | Malonylation | GDGSKKIKGCWDSIH CCCCCCCCCCCCEEE | 57.82 | 26320211 | |
159 | Acetylation | HVVEVQEKSSGRTAH EEEEEEECCCCCCEE | 32.60 | 23236377 | |
159 | 2-Hydroxyisobutyrylation | HVVEVQEKSSGRTAH EEEEEEECCCCCCEE | 32.60 | - | |
159 | Ubiquitination | HVVEVQEKSSGRTAH EEEEEEECCCCCCEE | 32.60 | - | |
160 | Phosphorylation | VVEVQEKSSGRTAHY EEEEEECCCCCCEEE | 36.95 | 26437602 | |
164 | Phosphorylation | QEKSSGRTAHYKLTS EECCCCCCEEEEEEE | 22.70 | 26437602 | |
170 | Phosphorylation | RTAHYKLTSTVMLWL CCEEEEEEEEEEEEE | 20.42 | 23403867 | |
171 | Phosphorylation | TAHYKLTSTVMLWLQ CEEEEEEEEEEEEEE | 29.46 | 20068231 | |
172 | Phosphorylation | AHYKLTSTVMLWLQT EEEEEEEEEEEEEEE | 12.52 | 23403867 | |
179 | Phosphorylation | TVMLWLQTNKSGSGT EEEEEEEECCCCCCE | 42.30 | 20068231 | |
182 | Phosphorylation | LWLQTNKSGSGTMNL EEEEECCCCCCEEEC | 40.02 | 25159151 | |
184 | Phosphorylation | LQTNKSGSGTMNLGG EEECCCCCCEEECCC | 37.88 | 25159151 | |
186 | Phosphorylation | TNKSGSGTMNLGGSL ECCCCCCEEECCCCC | 12.46 | 25159151 | |
187 | Sulfoxidation | NKSGSGTMNLGGSLT CCCCCCEEECCCCCE | 4.43 | 21406390 | |
192 | Phosphorylation | GTMNLGGSLTRQMEK CEEECCCCCEEHHHC | 25.43 | 25159151 | |
194 | Phosphorylation | MNLGGSLTRQMEKDE EECCCCCEEHHHCCC | 22.13 | - | |
197 | Sulfoxidation | GGSLTRQMEKDETVS CCCCEEHHHCCCCHH | 6.61 | 28465586 | |
199 | Ubiquitination | SLTRQMEKDETVSDC CCEEHHHCCCCHHHC | 56.36 | - | |
199 | Malonylation | SLTRQMEKDETVSDC CCEEHHHCCCCHHHC | 56.36 | 26320211 | |
199 | Acetylation | SLTRQMEKDETVSDC CCEEHHHCCCCHHHC | 56.36 | 23749302 | |
202 | Phosphorylation | RQMEKDETVSDCSPH EHHHCCCCHHHCCHH | 35.13 | 26126808 | |
204 | Phosphorylation | MEKDETVSDCSPHIA HHCCCCHHHCCHHHH | 40.08 | 26126808 | |
207 | Phosphorylation | DETVSDCSPHIANIG CCCHHHCCHHHHHHH | 25.22 | 27050516 | |
223 | Malonylation | LVEDMENKIRSTLNE HHHHHHHHHHHHHHH | 26.62 | 26320211 | |
223 | Acetylation | LVEDMENKIRSTLNE HHHHHHHHHHHHHHH | 26.62 | 23954790 | |
223 | Ubiquitination | LVEDMENKIRSTLNE HHHHHHHHHHHHHHH | 26.62 | - | |
223 | 2-Hydroxyisobutyrylation | LVEDMENKIRSTLNE HHHHHHHHHHHHHHH | 26.62 | - | |
226 | Phosphorylation | DMENKIRSTLNEIYF HHHHHHHHHHHHHHC | 40.49 | 23312004 | |
227 | Phosphorylation | MENKIRSTLNEIYFG HHHHHHHHHHHHHCC | 24.61 | 29083192 | |
232 (in isoform 2) | Phosphorylation | - | 10.49 | 28064214 | |
232 | Phosphorylation | RSTLNEIYFGKTKDI HHHHHHHHCCCHHHH | 10.49 | 18180459 | |
235 (in isoform 1) | Ubiquitination | - | 42.37 | 21890473 | |
235 | 2-Hydroxyisobutyrylation | LNEIYFGKTKDIVNG HHHHHCCCHHHHHHC | 42.37 | - | |
235 | Acetylation | LNEIYFGKTKDIVNG HHHHHCCCHHHHHHC | 42.37 | 19608861 | |
235 (in isoform 2) | Ubiquitination | - | 42.37 | 21890473 | |
235 | Ubiquitination | LNEIYFGKTKDIVNG HHHHHCCCHHHHHHC | 42.37 | 19608861 | |
235 | Ubiquitination | LNEIYFGKTKDIVNG HHHHHCCCHHHHHHC | 42.37 | 21890473 | |
236 | Phosphorylation | NEIYFGKTKDIVNGL HHHHCCCHHHHHHCH | 34.04 | 29083192 | |
237 | Ubiquitination | EIYFGKTKDIVNGLR HHHCCCHHHHHHCHH | 49.28 | - | |
245 (in isoform 2) | Phosphorylation | - | 29.84 | 20068231 | |
245 | Phosphorylation | DIVNGLRSIDAIPDN HHHHCHHCCCCCCCC | 29.84 | 26437602 | |
248 (in isoform 2) | Phosphorylation | - | 17.34 | 20068231 | |
252 (in isoform 2) | Ubiquitination | - | 41.40 | 21890473 | |
252 | Ubiquitination | SIDAIPDNQKFKQLQ CCCCCCCCHHHHHHH | 41.40 | 21890473 | |
253 (in isoform 2) | Phosphorylation | - | 61.00 | 20068231 | |
256 | Ubiquitination | IPDNQKFKQLQRELS CCCCHHHHHHHHHHH | 58.07 | - | |
263 | Phosphorylation | KQLQRELSQVLTQRQ HHHHHHHHHHHHHCC | 17.31 | 23911959 | |
267 (in isoform 2) | Ubiquitination | - | 23.89 | - | |
267 | Phosphorylation | RELSQVLTQRQIYIQ HHHHHHHHHCCEEEC | 23.89 | 28060719 | |
272 | Phosphorylation | VLTQRQIYIQPDN-- HHHHCCEEECCCC-- | 5.79 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CAPZB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CAPZB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAPZB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RM20_HUMAN | MRPL20 | physical | 16169070 | |
PTN_HUMAN | PTN | physical | 16169070 | |
BCCIP_HUMAN | BCCIP | physical | 16169070 | |
HSP7C_HUMAN | HSPA8 | physical | 20884878 | |
CAZA1_HUMAN | CAPZA1 | physical | 22939629 | |
PAPS1_HUMAN | PAPSS1 | physical | 22863883 | |
ARPC2_HUMAN | ARPC2 | physical | 26344197 | |
ARPC3_HUMAN | ARPC3 | physical | 26344197 | |
CNOT2_HUMAN | CNOT2 | physical | 26344197 | |
DCTN1_HUMAN | DCTN1 | physical | 26344197 | |
DCTN6_HUMAN | DCTN6 | physical | 26344197 | |
DDX53_HUMAN | DDX53 | physical | 26344197 | |
MYO5B_HUMAN | MYO5B | physical | 26344197 | |
SNAA_HUMAN | NAPA | physical | 26344197 | |
RPAP3_HUMAN | RPAP3 | physical | 26344197 | |
TMOD3_HUMAN | TMOD3 | physical | 26344197 | |
TOM40_HUMAN | TOMM40 | physical | 26344197 | |
TPM2_HUMAN | TPM2 | physical | 26344197 | |
UBL7_HUMAN | UBL7 | physical | 26344197 | |
DCTN2_HUMAN | DCTN2 | physical | 27173435 | |
DCTN1_HUMAN | DCTN1 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 2-14, AND ACETYLATION AT SER-2. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-235, AND MASS SPECTROMETRY. |